The retail pharmacy giant reported $1.22 earnings per share versus an expected $1.03 and revenue of $36.31 billion versus an expected $34.95.
Walgreens said its pharmacy sales grew as it filled more prescriptions and gave more flu shots, CNBC reported. Pharmacy sales rose 5 percent over last year, but the company also saw less foot traffic, lower sales of cough, cold and flu medications and fewer new prescriptions.
Walgreens shares have fallen about 28 percent in the last year, bringing its market value to $37.2 billion, according to CNBC.
Read the full article here.
More articles on pharmacy:
CVS names first chief customer officer
AmerisourceBergen to buy Walgreens’ Alliance Healthcare for $6.5B
Up to 6,000 pharmacies could begin giving COVID-19 vaccines in 2 weeks, HHS official says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
